TELA Bio stockholders approve 3.5M share increase to equity plan and officer liability limitation

TELA Bio, Inc.

Class III directors Blizard, Burgess, O'Brien elected; Burgess received only 9.75M votes for vs 19.54M withheld.
Equity plan amendment approved (20.03M for, 9.25M against); adds 3.5M shares, removes evergreen provision.
Charter amendment to limit officer liability passed (23.84M for, 5.41M against).
Non-binding say-on-pay approved with 23.03M for; annual frequency selected (26.94M for 1-year).
KPMG LLP ratified as auditor for 2025 with 31.84M votes for.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.